US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - Topstories https://ift.tt/3bIUCMT
Subscribe to:
Post Comments (Atom)
Set aside funds for likely defaults, RBI tells banks
The Reserve Bank of India has finalised new rules requiring banks to provision for expected loan losses from April 2027, shifting to a forwa...
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/mGFIOle
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
No comments:
Post a Comment